地拉罗司分散片说明书

Deferasirox (Enriga) is an iron chelator product developed by the Swiss pharmaceutical company Novartis. It is the first oral iron anthelmintic approved by the US FDA for routine use. It is approved for use in patients ≥2 years old with chronic iron overload caused by blood transfusion.

The therapeutic effect of Deferasirox (Enrig) is significant, but patients cannot blindly take this drug for treatment. Taking Deferasirox (Enrig) will also produce certain side effects or adverse reactions. The most common adverse reactions include: diarrhea/vomiting/headache/abdominal pain/fever/rash/increased serum creatinine, etc. Patients should undergo detailed examination before receiving deferasirox (Enrige) treatment and strictly follow the doctor's diagnosis and treatment recommendations.

Patients taking deferasirox (Enrige) should note:

Deferasirox (Enrige) may cause a rash. Generally, the rash will disappear automatically without the need to adjust the dosage or stop taking the medication; however, patients should stop taking the medication if the condition is severe or persistent.

Patients who are allergic to any of the ingredients in Deferasirox should not take this medicine for treatment.

Deferasirox (Enreg) should not be administered concurrently with aluminum-containing antacids. And deferasirox (Enrige) cannot be combined with other iron chelation treatments.

Deferasirox should be taken once daily on an empty stomach, at least 30 minutes before a meal, at the same time each day. Patients should not chew the tablets while taking this medicine.

CIPLA Pharmaceuticals, one of the well-known pharmaceutical companies in India, has launched a generic version of Deferasirox (Enrega), with a specification of 500mg*30 tablets/box and a price equivalent to RMB only about $500. The price is much lower than that of the original drug. Although it is a generic drug, its efficacy is almost the same as that of the original drug, and the price-performance ratio is high. Since the exchange rate is not fixed, if the price is not fixed, if patients want to know the specific price of the drug, or if they want to purchase Deferasirox (Enrige) overseas, they can consult with domestic reliable overseas medical service institutions (such as Medical Companion Travel).

The above is the introduction about Deferasirox (Enrego), I hope it can help everyone. If patients have other questions about the drug, they can consult the medical companion service.